ea0090ep701 | Pituitary and Neuroendocrinology | ECE2023
Nasybullina Farida
, Vagapova Gulnar
, Pashaev Bakhtiyar
, Ashimova Regina
It is known that treatment of prolactinomas with dopamine agonists is accompanied by relapses of the disease after discontinuation of the treatment in about 50% of cases and long-term or lifelong medication is required. The aim of the study was to evaluate the effectiveness of surgery in achieving remission or biochemical control of the disease. We prospectively enrolled 32 consecutive patients with prolactinomas who underwent transsphenoidal resection performed by the highly ...